ReproCELL reprocell.com


Public lists: Pharma Startups (4743)

ReproCell, established in 2003, is a developer of stem cell technologies. The company develops various products, with an underlying theme that focuses on stem cell technology, to address the needs of researchers and clinicians. The product range encompasses reagents for ES/iPS cells and stem cell-derived functional cells.

ReproCell, established in 2003, is a developer of stem cell technologies. The company develops various products, with an underlying theme that focuses on stem cell technology, to address the needs of researchers and clinicians. The product range enco...Show all

Company (Alive / Active)

Phone: +81-45-475-3887

Fax:

KDX Shin-Yokohama 381 Bldg. 8F
3-8-11,Shin-Yokohama, Kohoku-ku
Yokohama, 222-0033
Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ReproCELL $0M Apr 19, 2019
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ReproCELL Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Stemina Biomarker Discovery

Madison, Wisconsin, United States
Alive / ActiveStemina Cell Discovery discovers and validates small molecules as biomarkers for high-throughput drug screening and disease diagnostics using an all human system comprised of stem cells and the company's metabolomics platform. Metabolomics aims to enable the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity. The human embryonic stem cell metabolome is a source of candidate biomarkers to predict, diagnose or measure the progr...Show allLogin to see details

Keystone Nano

Boalsburg, Pennsylvania, United States
Alive / ActiveKeystone Nano seeks to improve human health by creating new ways to diagnose and treat human diseases and improve the quality of life. Keystone Nano partners with healthcare companies to the development and speed the market launch of nano-enabled therapeutics to seek/treat/image a variety of conditions.Login to see details
See all 16 competitors